zoanthenol analogue

ID: ALA91194

PubChem CID: 44323278

Max Phase: Preclinical

Molecular Formula: C22H27NO4

Molecular Weight: 369.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC1=C(C)C(=O)[C@](C)(CN2c3ccccc3[C@]3(O)CCOC23)C1=O

Standard InChI:  InChI=1S/C22H27NO4/c1-4-5-8-15-14(2)18(24)21(3,19(15)25)13-23-17-10-7-6-9-16(17)22(26)11-12-27-20(22)23/h6-7,9-10,20,26H,4-5,8,11-13H2,1-3H3/t20?,21-,22+/m0/s1

Standard InChI Key:  XPVQXXLKOCZMGG-JTGIGXABSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  1  0  0  0  0  0999 V2000
    0.2125   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8500   -2.1125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8500   -0.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5500   -3.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250   -2.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3667   -3.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5417   -2.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6375   -1.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5958   -2.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6375   -1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4375   -1.1792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1417   -4.5292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7375   -1.6917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -0.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2708   -0.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2042   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4375   -0.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2917   -2.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9250   -4.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3583   -0.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3583   -2.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9625   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7125   -2.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0708   -1.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0708   -1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3792   -3.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2 10  1  0
  3  2  1  0
  4  3  1  0
  5  1  1  0
  6  1  1  0
  7  5  1  0
  8  6  1  0
  9 11  1  0
 10  1  1  0
 11  2  1  0
 12  3  1  0
 13  5  2  0
 14  6  2  0
 15  4  1  0
  4 16  1  1
  1 17  1  1
 18 12  1  0
 19  8  1  0
 20  7  1  0
 21  9  2  0
 22 11  2  0
 23 19  1  0
 24 23  1  0
 25 26  2  0
 26 22  1  0
 27 24  1  0
  8  7  2  0
  9  4  1  0
 15 18  1  0
 25 21  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

IL6ST Tclin Interleukin-6 receptor subunit beta (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MH60 (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 369.46Molecular Weight (Monoisotopic): 369.1940AlogP: 3.11#Rotatable Bonds: 5
Polar Surface Area: 66.84Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.65CX Basic pKa: CX LogP: 4.49CX LogD: 4.49
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.81Np Likeness Score: 1.17

References

1. Hirai G, Oguri H, Hayashi M, Koyama K, Koizumi Y, Moharram SM, Hirama M..  (2004)  Synthesis and preliminary biological evaluation of truncated zoanthenol analogues.,  14  (10): [PMID:15109670] [10.1016/j.bmcl.2004.02.064]
2. Li H, Xiao H, Lin L, Jou D, Kumari V, Lin J, Li C..  (2014)  Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.,  57  (3): [PMID:24456369] [10.1021/jm401144z]

Source